Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
July 23rd, 2017
9.9K views
This protocol demonstrates murine islet isolation and seeding onto a decellularized scaffold. Scaffold-supported islets were transplanted into the epididymal fat pad of streptozotocin (STZ)-induced diabetic mice. Islets survived at the transplantation site and reversed the hyperglycemic condition.
Overview
This protocol demonstrates murine islet isolation and seeding onto a decellularized scaffold, followed by transplantation into diabetic mice. The study highlights the potential of scaffold-supported islets to reverse hyperglycemia.
Key Study Components
Area of Science
- Biomedical Engineering
- Diabetes Research
- Islet Transplantation
Background
- Type 1 diabetes is primarily managed with insulin injections.
- Islet transplantation can provide better blood glucose control.
- Challenges include the need for high-quality islets and poor engraftment efficiency.
- Decellularized scaffolds may improve islet survival and function post-transplant.
Purpose of Study
- To demonstrate the process of islet isolation and transplantation.
- To evaluate the survival of islets in a scaffold at the transplantation site.
- To assess the ability of transplanted islets to reverse hyperglycemia in diabetic mice.
Methods Used
- Isolation of murine islets from pancreatic tissue.
- Seeding islets onto a decellularized scaffold.
- Transplantation of scaffold-supported islets into the epididymal fat pad of diabetic mice.
- Monitoring islet survival and blood glucose levels post-transplant.
Main Results
- Islets survived at the transplantation site.
- Transplanted islets effectively reversed hyperglycemia in STZ-induced diabetic mice.
- Scaffold support enhanced islet engraftment and function.
- The protocol provides a viable method for islet transplantation research.
Conclusions
- Scaffold-supported islet transplantation shows promise for diabetes treatment.
- Further research is needed to optimize islet quality and engraftment.
- This method could potentially improve clinical outcomes for diabetic patients.
Frequently Asked Questions
What is the main goal of this study?
The main goal is to demonstrate islet isolation and transplantation techniques to reverse hyperglycemia in diabetic mice.
Why is islet transplantation important for diabetes?
Islet transplantation can provide stable blood glucose control without the severe fluctuations associated with insulin therapy.
What challenges does islet transplantation face?
Challenges include the need for high-quality islets and low engraftment efficiency.
How does the decellularized scaffold help islets?
The scaffold supports islet survival and function after transplantation.
What model organism is used in this study?
The study uses STZ-induced diabetic mice as the model organism.
What are the implications of this research?
This research could lead to improved methods for islet transplantation, enhancing treatment options for diabetes.
Executive Industry Relevance
Scaffold-supported islet transplantation addresses a critical bottleneck in diabetes research: poor engraftment efficiency at extrahepatic sites. By demonstrating rapid and sustained normoglycemia in diabetic mice using a decellularized scaffold at the epididymal fat pad, this method offers a reproducible platform for evaluating transplantation parameters. It enables mechanistic de-risking of islet engraftment strategies and supports predictive confidence in preclinical diabetes models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Provides a disease-relevant system to interrogate therapeutic hypotheses of islet survival and function post-transplant.
- Operational Value: Enables functional target validation by assessing glucose normalization as a direct readout of islet engraftment success.
Screening & Assay Development
- Scientific Value: Supports assay standardization through quantifiable outcomes like time-to-normoglycemia and graft retrieval for histological analysis.
- Operational Value: Offers a scalable platform for screening scaffold materials and transplantation variables affecting islet survival.
Translational & Preclinical Research
- Scientific Value: Establishes continuity from discovery to preclinical validation by maintaining normoglycemia for up to 3 months, enabling longitudinal study.
- Operational Value: Facilitates risk-adjusted advancement decisions through retrievable grafts and consistent engraftment metrics.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from islet isolation to engraftment assessment, supporting lead identification in diabetes therapeutics by providing a reliable preclinical readout.
- Discovery Biology: Supports hypothesis testing on islet survival mechanisms and pathway clarification in extrahepatic engraftment.
- Screening: Delivers assay readiness via standardized islet seeding on scaffolds and quantitative glucose monitoring.
- Analytics: Enables comparison of engraftment efficiency through time-to-reversal and maintenance of normoglycemia as key measurements.
- Translational Research: Connects to preclinical continuity through retrievable grafts and histological validation of revascularization.
- Enterprise Reuse: Frames the epididymal fat pad model as a reusable platform for testing multiple scaffold designs and transplantation parameters.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity in islet engraftment through scaffold-mediated improvement.
- Operational Value: Improves standardization and reproducibility via a defined surgical site and retrievable graft model.
- Strategic Value: Supports better go/no-go decisions by providing early, quantifiable engraftment data to de-risk preclinical candidates.
- Portfolio Impact: Enables risk-adjusted prioritization of islet transplantation approaches based on engraftment speed and durability.
Implementation Considerations
- Requires expertise in murine pancreatic perfusion, islet isolation, and microsurgical transplantation techniques.
- Dependent on instrumentation for cannulation, scaffold handling, and glucose monitoring systems.
- Necessitates cross-team standardization between isolation, scaffold preparation, and surgical teams for consistent outcomes.
- Involves adaptation considerations when transferring the model to other fat pad sites or genetic backgrounds.
- Limited by the need for skilled microsurgery to ensure complete fat pad encapsulation, as incomplete wrapping compromises engraftment.
Biopharma FAQs
Why does normoglycemia timing matter for target validation in islet transplantation?
The time to reverse hyperglycemia serves as a functional readout of islet engraftment efficiency, with scaffold-supported islets achieving normoglycemia in 10 days versus 30 days for free islets, enabling rapid assessment of transplantation success.
How does isolating high-yield islets support preclinical diabetes model development?
High-yield islet isolation ensures sufficient and consistent cell numbers for transplantation, reducing variability and enabling reliable testing of engraftment strategies in diabetic mouse models.
What quantitative measurements enable assessment of islet engraftment success?
Blood glucose levels are monitored post-transplant to determine time-to-normoglycemia and duration of maintenance, providing objective, quantifiable endpoints for engraftment evaluation.
Why does graft retrievability matter for cross-functional collaboration in diabetes research?
The ability to explant and histologically analyze grafts allows teams to validate revascularization and tissue integration, supporting shared interpretation of engraftment quality across discovery and preclinical groups.
What statistical analysis is required to compare scaffold-supported versus free islet transplantation outcomes?
Comparative analysis of engraftment speed and duration of normoglycemia between groups requires appropriate statistical testing to determine significant differences in transplantation efficacy.
Chapters in this video
0:00
Title
0:09
Introduction
1:03
Cannulation and Perfusion
3:55
Purification and Handpicking
6:30
Troubleshooting: Common Bile Duct Distended During Perfusion
7:03
Troubleshooting: Duodenum Distended During Perfusion
7:37
Islet Transplantation at EFP Site
10:23
Results
11:29
Conclusion
